Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Capecitabine price, strengths & recalls

Pharmacies pay $13.61 for 30 tablets of Capecitabine 500 mg tablet this week, and from $10.85 to $13.61 across its 2 priced strengths and forms. 16 manufacturers make it. It has 5 recalls on record, none ongoing. Its official label last changed on May 13, 2026.

Generic
Pharmacies pay$13.61for 30 tablets of 500 mg tablet-0.4% in 4 weeks
Fair cash price
$26.15
Strengths
2
Makers
16
Updated
Nov 11

Capecitabine price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
150 mg tablet$0.3615$10.85 / 30 tabletsNo change-8.6%
500 mg tablet$0.4538$13.61 / 30 tablets-0.4%-10.4%

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recalls5 recalls on record, latest May 16, 2018

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for capecitabine? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedMay 13, 2026
Version3 of 3
EffectiveMay 12, 2026
Read the label

These highlights do not include all the information needed to use CAPECITABINE TABLETS safely and effectively. See full prescribing information for CAPECITABINE TABLETS. CAPECITABINE tablets, for oral use Initial U.S. Approval: 1998

This drug has a boxed warning

WARNING: SERIOUS ADVERSE REACTIONS OR DEATH IN PATIENTS WITH COMPLETE DPD DEFICIENCY and INCREASED RISK OF BLEEDING WITH CONCOMITANT USE OF VITAMIN K ANTAGONISTS

Increased risk of serious adverse reactions or death in patients with complete DPD deficiency

• Test patients for genetic variants of

DPYD prior to initiating capecitabine unless immediate treatment is necessary. Avoid use of capecitabine in patients with certain homozygous or compound heterozygous

DPYD variants that result in complete DPD deficiency

[see

Warnings and Precautions (5.1)]

.

Increased risk of bleeding with concomitant use of Vitamin K antagonists

• Altered coagulation parameters and/or bleeding, including death, have been reported in patients taking capecitabine concomitantly with oral vitamin K antagonists, such as warfarin

[see

Warnings and Precautions (5.2),

Drug Interactions (7.2)]

.

• Clinically significant increases in prothrombin time (PT) and international normalized ratio (INR) have been reported in patients who were on stable doses of a vitamin K antagonist at the time capecitabine was introduced. These events occurred in patients with and without liver metastases.

• Monitor INR more frequently and adjust the dose of the vitamin K antagonist as appropriate

[see

Drug Interactions (7.2)]

.

WARNING: SERIOUS ADVERSE REACTIONS OR DEATH IN PATIENTS WITH COMPLETE DPD DEFICIENCY and BLEEDING WITH CONCOMITANT USE OF VITAMIN K ANTAGONISTS

See full prescribing information for complete boxed warning.

Serious adverse reactions or death may occur in patients with complete DPD deficiency. Test patients for genetic variants of

DPYDprior to initiating Capecitabine tablet unless immediate treatment is necessary. Avoid use of Capecitabine tablet in patients with certain homozygous or compound heterozygous

DPYDvariants that result in complete DPD deficiency.

(5.1)

Altered coagulation parameters and/or bleeding, including death, have been reported in patients taking capecitabine concomitantly with oral vitamin K antagonists.

(5.2, 7.2) Monitor international normalized ratio (INR) more frequently and adjust the dose of the vitamin K antagonist as appropriate.

(7.2)

Recent major changes (as listed on the label)

Boxed Warning (10/2025)

Dosage and Administration (2.1) (10/2025)

Warnings and Precautions (5.1) (10/2025)

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
10 approved generic applications on the market

Capecitabine questions

How much does capecitabine cost without insurance?

Pharmacies pay about $13.61 for 30 tablets of capecitabine 500 mg tablet ($0.4538 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $26.15. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is capecitabine in shortage?

No shortage is reported for capecitabine right now. We check the national shortage list every day.

Has capecitabine been recalled?

5 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the capecitabine label last change?

The official label was last updated on May 13, 2026 (version 3). See what changed.

Talk about capecitabine

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.